← Open Payments lookup

SAMEER ARAIN: Open Payments

NPI 1750305546 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,838 in 100 payments from 12 companies in 2025. Trend: 2023 $485 · 2024 $512 · 2025 $1,838

Food & beverage: $1,831Education: $8
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.46$557
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$309
Axsome Therapeutics, Inc.4$261
Alkermes, Inc.5$220
Otsuka America Pharmaceutical, Inc.12$199
Teva Pharmaceuticals USA, Inc.5$81
Vanda Pharmaceuticals Inc.4$69
Neurocrine BioSciences, Inc.3$54
Janssen Pharmaceuticals, Inc2$33
Luye Pharma (USA) Ltd.1$23

Products named: COBENFY, CAPLYTA, Auvelity, REXULTI, LYBALVI, UZEDY, FANAPT, ABILIFY MAINTENA.

Industry payments across MO — which companies pay providers there.